MIKHAIL GRINBERG

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology BROOKLYN, NY NPI 1013917400

General Payments — all program years on this page

$22,342.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 249
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,422.34 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $3,000.003
Food and Beverage $422.3418

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $5,142.4853
2019 $1,929.7148
2020 $1,960.7341
2021 $6,016.5739
2022 $3,570.7836
2023 $300.3211
2024 $3,422.3421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105528862 AstraZeneca Pharmaceuticals LP $525.00 08/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105598521 AstraZeneca Pharmaceuticals LP $22.50 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105637444 AstraZeneca Pharmaceuticals LP $27.50 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105679717 AstraZeneca Pharmaceuticals LP $525.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110766885 Eisai Inc. $28.16 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113846208 PUMA BIOTECHNOLOGY, INC. $25.24 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113850381 PUMA BIOTECHNOLOGY, INC. $19.66 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116328896 GlaxoSmithKline, LLC. $23.90 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117168470 Mirati Therapeutics, Inc. $25.65 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120867204 BeiGene USA, Inc. $1,950.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135207484 Lilly USA, LLC $22.29 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135246338 Lilly USA, LLC $21.35 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139327808 Astellas Pharma US Inc $22.84 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139430014 Astellas Pharma US Inc $16.02 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600936 GENZYME CORPORATION $26.18 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141259459 Incyte Corporation $22.51 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141780955 Merck Sharp & Dohme LLC $25.86 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141944059 Merck Sharp & Dohme LLC $18.54 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147278650 Coherus Biosciences Inc. $23.94 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150195253 JAZZ PHARMACEUTICALS INC. $25.30 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150656781 Spectrum Pharmaceuticals Inc. $24.90 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.